Sihuan Pharmaceutical Holdings Stock Shares Outstanding
SHPHFDelisted Stock | USD 0.1 0.00 0.00% |
Sihuan Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Sihuan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Sihuan Pink Sheet. The fundamental analysis module provides a way to measure Sihuan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sihuan Pharmaceutical pink sheet.
Sihuan |
Sihuan Pharmaceutical Holdings Company Shares Outstanding Analysis
Sihuan Pharmaceutical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Sihuan Pharmaceutical Shares Outstanding | 9.33 B |
Most of Sihuan Pharmaceutical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sihuan Pharmaceutical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Sihuan Pharmaceutical Holdings has 9.33 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is significantly lower than that of the firm.
Sihuan Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sihuan Pharmaceutical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sihuan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sihuan Pharmaceutical by comparing valuation metrics of similar companies.Sihuan Pharmaceutical is currently under evaluation in shares outstanding category among its peers.
Sihuan Fundamentals
Return On Equity | -0.0487 | |||
Return On Asset | -4.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0) % | |||
Current Valuation | 506.36 M | |||
Shares Outstanding | 9.33 B | |||
Shares Owned By Insiders | 55.02 % | |||
Shares Owned By Institutions | 4.21 % | |||
Price To Earning | 8.75 X | |||
Price To Book | 0.81 X | |||
Price To Sales | 0.41 X | |||
Revenue | 3.29 B | |||
Gross Profit | 2.45 B | |||
EBITDA | 914.73 M | |||
Net Income | 416.51 M | |||
Cash And Equivalents | 5.25 B | |||
Cash Per Share | 0.56 X | |||
Total Debt | 844.75 M | |||
Debt To Equity | 0.14 % | |||
Current Ratio | 2.43 X | |||
Book Value Per Share | 0.78 X | |||
Cash Flow From Operations | 665.29 M | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 3.9 K | |||
Beta | 0.8 | |||
Market Capitalization | 1.2 B | |||
Total Asset | 14.5 B | |||
Retained Earnings | 5.54 B | |||
Working Capital | 4.66 B | |||
Current Asset | 6.17 B | |||
Current Liabilities | 1.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Net Asset | 14.5 B | |||
Last Dividend Paid | 0.014 |
About Sihuan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sihuan Pharmaceutical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sihuan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sihuan Pharmaceutical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world |